Advanced

Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.

Prasad, Mahadesh A J; Ungerbäck, Jonas; Åhsberg, Josefine; Somasundaram, Rajesh; Strid, Tobias; Larsson, Malin; Månsson, Robert; De Paepe, Ayla; Lilljebjörn, Henrik LU and Fioretos, Thoas LU , et al. (2015) In Blood 125(26). p.4052-4059
Abstract
Ebf1 is a transcription factor with documented dose dependent functions in normal and malignant B-lymphocyte development. To understand more about the roles of Ebf1 in malignant transformation, we investigated the impact of reduced functional Ebf1 dosage on mouse B-cell progenitors. Gene expression analysis suggested that Ebf1 was involved in the regulation of genes important for DNA repair as well as cell survival. Investigation of the DNA damage in steady state as well as after induction of DNA damage by UV light, confirmed that pro-B cells lacking one functional allele of Ebf1 display signs of increased DNA damage. This correlated to reduced expression of DNA repair genes including Rad51 and chromatin immunoprecipitation data suggested... (More)
Ebf1 is a transcription factor with documented dose dependent functions in normal and malignant B-lymphocyte development. To understand more about the roles of Ebf1 in malignant transformation, we investigated the impact of reduced functional Ebf1 dosage on mouse B-cell progenitors. Gene expression analysis suggested that Ebf1 was involved in the regulation of genes important for DNA repair as well as cell survival. Investigation of the DNA damage in steady state as well as after induction of DNA damage by UV light, confirmed that pro-B cells lacking one functional allele of Ebf1 display signs of increased DNA damage. This correlated to reduced expression of DNA repair genes including Rad51 and chromatin immunoprecipitation data suggested that Rad51 is a direct target for Ebf1. Although reduced dosage of Ebf1 did not significantly increase tumor formation in mice, a dramatic increase in the frequency of pro-B cell leukemia was observed in mice with combined heterozygous mutations in the Ebf1 and Pax5 genes revealing a synergistic effect of combined dose reduction of these proteins. Our data suggest that Ebf1 controls DNA repair in a dose dependent manner providing a possible explanation to the frequent involvement of EBF1 gene loss in human leukemia. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
125
issue
26
pages
4052 - 4059
publisher
American Society of Hematology
external identifiers
  • pmid:25838350
  • wos:000357284300016
  • scopus:84933557673
ISSN
1528-0020
DOI
10.1182/blood-2014-12-617282
language
English
LU publication?
yes
id
9c774105-87dc-40f6-9486-4c11bae2cf52 (old id 5360125)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25838350?dopt=Abstract
date added to LUP
2015-05-07 00:05:11
date last changed
2017-09-17 04:02:15
@article{9c774105-87dc-40f6-9486-4c11bae2cf52,
  abstract     = {Ebf1 is a transcription factor with documented dose dependent functions in normal and malignant B-lymphocyte development. To understand more about the roles of Ebf1 in malignant transformation, we investigated the impact of reduced functional Ebf1 dosage on mouse B-cell progenitors. Gene expression analysis suggested that Ebf1 was involved in the regulation of genes important for DNA repair as well as cell survival. Investigation of the DNA damage in steady state as well as after induction of DNA damage by UV light, confirmed that pro-B cells lacking one functional allele of Ebf1 display signs of increased DNA damage. This correlated to reduced expression of DNA repair genes including Rad51 and chromatin immunoprecipitation data suggested that Rad51 is a direct target for Ebf1. Although reduced dosage of Ebf1 did not significantly increase tumor formation in mice, a dramatic increase in the frequency of pro-B cell leukemia was observed in mice with combined heterozygous mutations in the Ebf1 and Pax5 genes revealing a synergistic effect of combined dose reduction of these proteins. Our data suggest that Ebf1 controls DNA repair in a dose dependent manner providing a possible explanation to the frequent involvement of EBF1 gene loss in human leukemia.},
  author       = {Prasad, Mahadesh A J and Ungerbäck, Jonas and Åhsberg, Josefine and Somasundaram, Rajesh and Strid, Tobias and Larsson, Malin and Månsson, Robert and De Paepe, Ayla and Lilljebjörn, Henrik and Fioretos, Thoas and Hagman, James and Sigvardsson, Mikael},
  issn         = {1528-0020},
  language     = {eng},
  number       = {26},
  pages        = {4052--4059},
  publisher    = {American Society of Hematology},
  series       = {Blood},
  title        = {Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.},
  url          = {http://dx.doi.org/10.1182/blood-2014-12-617282},
  volume       = {125},
  year         = {2015},
}